Physician profile
Jon Oletsky
NPI 1437159472
$695.92
in general payments reported to CMS, 2019-2025
18 companies · $239 in 2025
The $239 reported for 2025 was more than what 84% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $52.11 · 2021: $38.69 · 2023: $78.80 · 2024: $166 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $170.46 | 2019-2025 | Bridion, Keytruda, Welireg |
| Bayer Healthcare Pharmaceuticals INC. | $58.87 | 2021-2024 | |
| Renovia INC | $57.73 | 2019 | |
| Teleflex LLC | $48.49 | 2024 | Urolift |
| Tolmar, INC. | $47.02 | 2024-2025 | Eligard, Jatenzo |
| Progenics Pharmaceuticals, INC. | $43.22 | 2024-2025 | |
| Chiesi USA, INC. | $33.72 | 2019 | |
| Boston Scientific Corporation | $30.51 | 2025 | Spaceoar Vue System - 10ml |
| Urogen Pharma, INC. | $27.24 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $25.53 | 2025 | Iovera, Exparel |
| Janssen Biotech, INC. | $24.01 | 2025 | Erleada |
| Sumitomo Pharma America, INC. | $21.83 | 2024 | Gemtesa |
| Fisher & Paykel Healthcare INC | $21.50 | 2023 | Fisher & Paykel Healthcare |
| Blue Earth Diagnostics | $19.05 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $18.75 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mindray Ds USA, INC. | $17.18 | 2023 | A7 Anesthesia System |
| Endo USA, INC. | $17.03 | 2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Oletsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.